WO2026022742 - CBL-B INHIBITOR AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2026/022742
Publication Date
29.01.2026
International Application No.
PCT/IB2025/057485
International Filing Date
23.07.2025
Title **
[English]
CBL-B INHIBITOR AND USES THEREOF
[French]
INHIBITEUR DE CBL-B ET SES UTILISATIONS
Applicants **
BRIDGENE BIOSCIENCES LIMITED
Inventors
LUO, Zhushou
JANSA, Petr
ZHANG, Chao
Priority Data
63/674,576
23.07.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 17555 | |
| EPO | Filing, Examination, Granting | 571169 | |
| Japan | Filing, Examination, Granting | 6913 | |
| South Korea | Filing, Examination, Granting | 28173 | |
| USA | Filing, Examination, Granting | 106340 |
Total:
730,150
Contact Us
Abstract[English]
are absent when the (d) represents a triple bond.[French]
étant absents lorsque (d) représente une liaison triple.